全文获取类型
收费全文 | 16238篇 |
免费 | 1455篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 155篇 |
儿科学 | 478篇 |
妇产科学 | 294篇 |
基础医学 | 2128篇 |
口腔科学 | 525篇 |
临床医学 | 1891篇 |
内科学 | 3320篇 |
皮肤病学 | 199篇 |
神经病学 | 1516篇 |
特种医学 | 524篇 |
外国民族医学 | 3篇 |
外科学 | 1914篇 |
综合类 | 391篇 |
一般理论 | 13篇 |
预防医学 | 1704篇 |
眼科学 | 328篇 |
药学 | 1226篇 |
中国医学 | 4篇 |
肿瘤学 | 1101篇 |
出版年
2021年 | 215篇 |
2020年 | 136篇 |
2019年 | 209篇 |
2018年 | 235篇 |
2017年 | 192篇 |
2016年 | 206篇 |
2015年 | 226篇 |
2014年 | 337篇 |
2013年 | 457篇 |
2012年 | 729篇 |
2011年 | 712篇 |
2010年 | 396篇 |
2009年 | 343篇 |
2008年 | 664篇 |
2007年 | 681篇 |
2006年 | 698篇 |
2005年 | 667篇 |
2004年 | 694篇 |
2003年 | 633篇 |
2002年 | 555篇 |
2001年 | 588篇 |
2000年 | 595篇 |
1999年 | 512篇 |
1998年 | 222篇 |
1997年 | 168篇 |
1996年 | 178篇 |
1995年 | 198篇 |
1994年 | 163篇 |
1993年 | 165篇 |
1992年 | 457篇 |
1991年 | 417篇 |
1990年 | 421篇 |
1989年 | 403篇 |
1988年 | 338篇 |
1987年 | 330篇 |
1986年 | 285篇 |
1985年 | 285篇 |
1984年 | 207篇 |
1983年 | 203篇 |
1982年 | 155篇 |
1981年 | 130篇 |
1980年 | 135篇 |
1979年 | 214篇 |
1978年 | 152篇 |
1977年 | 135篇 |
1976年 | 148篇 |
1974年 | 143篇 |
1973年 | 161篇 |
1972年 | 136篇 |
1970年 | 125篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
21.
LM985 has been shown previously to hydrolyse to flavone acetic acid (LM975) in mouse plasma and to produce significant anti-tumour effects in transplantable mouse colon tumours (MAC). It has undergone Phase I clinical trials and dose limiting toxicity was acute reversible hypotension. Substantially higher doses of LM975 can be given clinically without dose limiting toxicity. We have investigated the activity of LM975 against a panel of MAC tumours and also the in vitro cytotoxicity of both LM985 and LM975 in two cell lines derived from MAC tumours. LM985 is considerably more cytotoxic than LM975 in vitro but increased length of exposure to LM975 results in improved activity. Single in vivo injection of LM975 showed no activity against the ascitic tumour MAC 15A, moderate activity against the s.c. poorly differentiated tumour MAC 13 and produced a significant growth delay in the well differentiated MAC 26. These latter responses were considerably enhanced by repeated injection 7 days later. Pharmacokinetic studies in mice following i.p. injection of LM985 demonstrated rapid degradation of LM985 to LM975 in the peritoneum. Length of exposure as well as drug concentration appear important factors in determining anti-tumour responses. 相似文献
22.
M D Stonard P G Phillips J R Foster M G Simpson E A Lock 《Clinica chimica acta; international journal of clinical chemistry》1986,160(2):197-203
The concentration of renal alpha 2U-globulin increased in a dose-dependent manner in adult male but not female rats which received a single dose of 2,2,4-trimethylpentane (TMP). After administration of a single dose of 12 mmol TMP/kg to adult male rats, the renal concentration of alpha 2U-globulin reached a peak at 48 hours and returned to near background level after 7 days. These changes in renal alpha 2U-globulin concentration were closely paralleled by changes in renal hyaline droplet formation. Renal alpha 2U-globulin and hyaline droplets were absent in normal pre-puberty male rats, and neither could be stimulated by a single dose of TMP. alpha 2U-Globulin was localised in the renal cortex of adult male rats, in particular the S2 segment of the proximal tubule. A greater staining intensity due to alpha 2U-globulin was seen in the S2 and adjacent segments after a single dose of TMP. A strong association is suggested between the presence of renal hyaline droplets and the occurrence of alpha 2U-globulin. 相似文献
23.
24.
The effect of time of day of drug administration on triazolam pharmacokinetics was studied in ten healthy men. In a randomized, two-way, crossover investigation, each subject received one 0.5 mg triazolam tablet either in the morning (7 AM) or evening (10 PM). Blood samples were obtained immediately before dosing and at selected times up to 12 hours after dosing. Triazolam plasma concentrations were determined by gas chromatography with electron capture detection. Psychomotor performance tests, including digit symbol substitution, card sorting by suits, and card sorting by fours, were administered, and the subjects' sedation was rated before drug and at two, ten, and 12 hours after drug administration. In addition, anterograde amnesia was assessed by showing objects to subjects two hours after dosing and testing aided and unaided recall at ten hours following administration. Triazolam's apparent elimination half-life after evening administration was significantly longer than after daytime ingestion (3.77 hr vs. 2.94 hr, P less than .05). There was no difference between times of dosing in total oral clearance or apparent volume of distribution. The absorption of triazolam was slower after evening administration, with an absorption half-life of 21.9 vs 13.3 minutes after daytime dosing. Performance decrements were significantly greater two hours after dosing in evening than in the daytime, but anterograde amnesia was more pronounced after daytime dosing. There was no effect on psychomotor performance at ten or 12 hours after administration in daytime or evening. These results indicate temporal variation in triazolam absorption and elimination.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
25.
26.
27.
28.
Reduced blood clearance and increased urinary excretion of N-nitrosodimethylamine in patas monkeys exposed to ethanol or isopropyl alcohol. 总被引:1,自引:0,他引:1
L M Anderson R Koseniauskas E S Burak T J Moskal C T Gombar J M Phillips E B Sansone S Keimig P N Magee J M Rice 《Cancer research》1992,52(6):1463-1468
Low concentrations of N-nitrosodimethylamine are metabolized in rodent and human liver by cytochrome P450IIE1, an activity competitively inhibitable by ethanol. In rodents coadministration of ethanol with N-nitrosodimethylamine results in increased tumorigenicity in extrahepatic organs, probably as a result of reduced hepatic clearance. To test this concept in a primate, the effects of ethanol cotreatment on the pharmacokinetics of N-nitrosodimethylamine were measured in male patas monkeys. Ethanol, 1.2 g/kg given p.o. before i.v. N-nitrosodimethylamine (1 mg/kg) or concurrently with an intragastric dose resulted in a 10-50-fold increase in the area under the blood concentration versus time curves and a 4-13-fold increase in mean residence times for N-nitrosodimethylamine. Isopropyl alcohol, 3.2 g/kg 24 h before N-nitrosodimethylamine, also increased these parameters 7-10-fold; this effect was associated with persistence of isopropyl alcohol and its metabolic product acetone, both IIE1 inhibitors, in the blood. While no N-nitrosodimethylamine was detected in expired air, trace amounts were found in urine. Ethanol and isopropyl alcohol pretreatment increased the maximum urinary N-nitrosodimethylamine concentration 15-50-fold and the percentage of the dose excreted in the urine by 100-800-fold. Thus ethanol and isopropyl alcohol greatly increase systemic exposure of extrahepatic organs to N-nitrosodimethylamine in a primate. 相似文献
29.
30.
A N Phillips J D Neaton D G Cook R H Grimm A G Shaper 《American journal of epidemiology》1992,136(1):59-70
The association between leukocyte count and subsequent risk of major coronary heart disease events was examined using data from three prospective cohort studies--two from the United States and one from Great Britain. A total of 28,181 middle-aged men were followed for 6-12 years. A total of 1,768 men had a nonfatal myocardial infarction or died of coronary heart disease. In all three cohorts, there was a positive, statistically significant relation between baseline leukocyte count and risk of subsequent major coronary heart disease events after adjustment for age, serum total cholesterol, diastolic blood pressure, and number of cigarettes smoked per day (relative odds = 1.32 (p less than 0.0001), 1.15 (p = 0.0001), and 1.14 (p = 0.003), corresponding to a 2,000/mm3 difference in leukocyte count). The associations persisted when all nonsmokers (former smokers plus never smokers) and never smokers alone were considered and when those with evidence of preexisting coronary heart disease at baseline were excluded. Leukocyte count appears to be an indicator of a person's future risk of major coronary heart disease events. 相似文献